Fortress Biotech and Cyprium Therapeutics Announce Positive Clinical Data for CUTX-101, Copper ...
Cyprium Therapeutics, a partner company of Fortress Biotech, is developing CUTX-101 for the treatment of Menkes disease
Source: kulr8.com
Stay updated with breaking news from Technology Program Authors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cyprium Therapeutics, a partner company of Fortress Biotech, is developing CUTX-101 for the treatment of Menkes disease